首页> 外文OA文献 >Phase I Dose-Finding Study of OPB-111077, a Novel STAT3 Inhibitor, in Patients with Advanced Hepatocellular Carcinoma

【2h】

Phase I Dose-Finding Study of OPB-111077, a Novel STAT3 Inhibitor, in Patients with Advanced Hepatocellular Carcinoma

机译：IPB-111077，一种新型STAT3抑制剂OPB-111077，患有晚期肝细胞癌患者的IPB-111077的剂量研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Changhoon Yoo; Jihoon Kang; Ho Yeong Lim; Jee Hyun Kim; Myung-Ah Lee; Kyung-Hun Lee; Tae-You Kim; Baek-Yeol Ryoo;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A phase I dose-finding study of silybin phosphatidylcholine (milk thistle) in patients with advanced hepatocellular carcinoma [J] . SiegelA.B., NarayanR., RodriguezR., Integrative cancer therapies . 2014,第1期

机译：水飞蓟宾磷脂酰胆碱（乳蓟）在晚期肝细胞癌患者中的I期剂量研究
2. A Phase I Dose-Finding Study of Silybin Phosphatidylcholine (Milk Thistle) in Patients With Advanced Hepatocellular Carcinoma [J] . Abby B. Siegel, Rupa Narayan, Rosa Rodriguez, Integrative cancer therapies. . 2014,第1期

机译：晚期肝细胞癌患者中水飞蓟宾磷脂酰胆碱（乳蓟）的I期剂量发现研究
3. Erratum to A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma [J] . Therapeutic advances in medical oncology. . 2020,第12期

机译：II期的误诊研究了Met抑制剂Capmatinib（Inc280）在先进的肝细胞癌患者中的疗效和安全性研究
4. Diffusion-weighted MR imaging of advanced hepatocellular carcinoma treated with the oral multikinase inhibitor Sorafenib [C] . C. Schraml, N.F. Schwenzer, H. Rempp, World congress on medical physics and biomedical engineering;International congress of the IUPESM . 2011

机译：口服多激酶抑制剂索拉非尼治疗晚期肝癌的扩散加权MR成像
5. Capture and Analysis of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma---Analysis of a Pilot Study [D] . Dong, Cheng. 2014

机译：肝细胞癌患者循环肿瘤细胞的捕获和分析---一项初步研究分析
6. Phase I Dose-Finding Study of OPB-111077 a Novel STAT3 Inhibitor in Patients with Advanced Hepatocellular Carcinoma [O] . Changhoon Yoo, Jihoon Kang, Ho Yeong Lim, 2019

机译：新型STAT3抑制剂OPB-111077在晚期肝细胞癌患者中的I期剂量发现研究
7. A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma [O] . Shukui Qin, Stephen Lam Chan, Wattana Sukeepaisarnjaroen, 2019

机译：II期关于高级肝细胞癌患者的Met抑制剂Capmatinib（Inc280）的疗效和安全性研究

Phase I Dose-Finding Study of OPB-111077, a Novel STAT3 Inhibitor, in Patients with Advanced Hepatocellular Carcinoma

著录项

引文网络

相似文献

相关主题

期刊订阅